Intro

This chapter delves into the Federal Trade Commission's attempts to block the $28 billion merger between Amgen and Horizon Therapeutics, highlighting concerns over industry consolidation. It also addresses international news, including Ukraine's defense against a missile attack and Italy's challenges in using COVID recovery funds.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app